PR Newswire
REHOVOT, Israel , Dec. 28, 2022 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced it will be in attendance at the Healthcare Week taking place together with the J.P. Morgan Healthcare Conference in San Francisco . The conference is one of the industry's largest conferences of the year.
This follows Biomica's recent successful financing round of $20 million , led by Shanghai Healthcare Capital, a leading Chinese private equity fund.
In attendance will be Dr. Elran Haber, CEO of Biomica, throughout the week from Monday, January 9 until Wednesday, January 11, 2023 .
Dr. Haber will be available for one-on-one meetings throughout the week, and those interested should be in touch with Biomica's investor or public relations team.
About Biomica
Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing a dedicated Computational Predictive Biology platform (CPB), licensed from Evogene. Biomica aims to identify and characterize disease-related microbiome entities and to develop novel therapeutics based on these understandings. The company is focused on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. Biomica is a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN). For more information, please visit www.biomicamed.com .
Logo - https://mma.prnewswire.com/media/1974949/Biomica_Logo.jpg
Logo - https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg
Evogene Investor Contact:
Kenny Green
kenny.green@evogene.com
+1 (212) 378 8040
SOURCE Biomica Ltd.